Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 140.00
-9.50 (-6.35%)
Mar 4, 2026, 1:30 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 231.72 billion as of March 3, 2026. Its market cap has increased by 136.34% in one year.
Market Cap
231.72B
Enterprise Value
225.21B
Revenue
34.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
140.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 231.72B, an increase of 2,811.69%. That is a compound annual growth rate of 188.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 231.72B | -3.55% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pell Bio-Med Technology | 44.56B |
| Lin BioScience | 35.99B |
| Lumosa Therapeutics | 29.14B |
| Oneness Biotech | 27.84B |
| Polaris Group | 24.62B |
| Sunmax Biotechnology | 21.57B |
| EirGenix | 18.52B |
| AP Biosciences | 15.15B |